Published Date: 13-Oct-2021
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Global ePharmacy Market, published by KBV research, The Global ePharmacy Market size is expected to reach $167.6 billion by 2027, rising at a market growth of 16.4% CAGR during the forecast period.
The Over-the-Counter Drugs Segment is anticipated to display the fastest growth rate over the forecasting years. The industrial trends that are responsible for the growth of the segment are the increasing tendency of people toward self-medication in emerging regions, changing preferences of customers towards ePharmacies, Rx to OTC switch by pharmaceutical manufacturers, and rising burden of pain. The surge in patent expiration rates encourages the companies to shift from Rx to OTC.
The Asia Pacific would exhibit the fastest growth rate over the forecasting period. The growing number of government initiatives supporting the deployment of digital technologies and the rising population in developing nations like India & China are some factors driving the growth of the regional market. Additionally, there are a growing number of strategic initiatives taken by several private & public companies that are expected to boost the growth of the regional market.
Full Report: https://www.kbvresearch.com/epharmacy-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of The Kroger Co., Walgreen Co., Giant Eagle, Inc., Walmart, Inc., Express Scripts Holding Company (Cigna), CVS Health (CVS Pharmacy, Inc.), Optum Rx, Inc. (United Health Group), Rowlands Pharmacy (the PHOENIX group), DocMorris (Zur Rose Group AG), and Amazon Pharmacy (Amazon.com).
By Drug Type
Unique Offerings from KBV Research